
NYSE:VTR
This summary was created by AI, based on 3 opinions in the last 12 months.
Ventas Inc (VTR-N) is a notable player in the healthcare REIT sector, particularly recognized for its strong positioning in nursing and retirement homes. With a consistent track record showcasing a remarkable 2,177% increase in share value since 2000, the company has established a reputation for solid long-term performance. The firm operates under the leadership of a seasoned CEO, who has guided it since 1999, contributing to its reliability and strategic growth. Currently, the stock is experiencing an upward trend with a 17% increase this year; however, it appears slightly overbought, suggesting that buying dips could be a wise strategy for investors. As a growth stock within seniors housing, Ventas is poised for continued expansion, supported by a projected 10% earnings growth and its favorable 20x FFO ratio.
He likes the healthcare space, and this company owns medical office buildings, seniors’ homes, etc. This is generally a good business. However, being structured as a REIT, it has had a huge, huge run in share price and trades at a fairly steep valuation. It is vulnerable to interest rates coming down. He prefers Capital Senior Living (CSU-N) which trades at a much more modest valuation. Dividend yield of 4.2%.
A healthcare REIT. He owns a similar one. They are growth vehicles and trade significantly above NAV because they are constantly acquiring. The prices come off when there is a sign their acquisitions will drop off. They are looking at Canada. He thinks you are better buying companies they may want to acquire, however.
Seniors housing REIT in the US. He likes it. It has been clobbered. The decline is based on the broader US REIT index. People are getting older and you should see an increase in demand for seniors housing. You should see good rent increases. It is a little bit growth by acquisition based which is harder when you are trading at a discount.
Ventas Inc is a American stock, trading under the symbol VTR (previously VTR-N on Stockchase) on the New York Stock Exchange (VTR). It is usually referred to as NYSE:VTR or VTR
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on VTR (previously VTR-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is . Read the latest stock experts' ratings for Ventas Inc.
Ventas Inc was recommended as a Top Pick by Derek Warren on 2014-06-13. Read the latest stock experts ratings for Ventas Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Ventas Inc.
Ventas Inc is followed by 8 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-08, Ventas Inc (VTR) stock closed at a price of $93.13.
Nursing homes. 20x FFO and 10% earnings growth.